Groupon Inc. (NASDAQ:GRPN) reported fourth quarter results that fell short of analyst expectations, with both earnings and revenue missing estimates as the company conti ...
ARLINGTON, Va. - AeroVironment, Inc. (NASDAQ:AVAV) reported third quarter results that fell short of analyst expectations, with shares dropping 8.2% following the announcement as investors reacted to ...
(NYSE:LDI) reported fourth quarter results that fell short of analyst expectations, with revenue declining 4% to $310 million compared to the cons ...
Investing.com -- The United States has not escorted any oil tankers or vessels through the Strait of Hormuz, White House Press Secretary Karoline Leavitt said Tuesday.
Adecco Group AG on Tuesday cut its annual dividend by 60% and reported a decline in adjusted earnings per share after its ...
Investing.com -- Bank of America (NYSE:BAC) reported first-quarter net interest income increased at least 7% year-over-year, according to co-president Athanasia speaking at an RBC conference on ...
Persimmon posted full-year profit above its own guidance on Tuesday and said early 2026 sales were running ahead of last year ...
Data from Goldman Sachs shows short exposure across U.S. macro products — including index and ETF positions — has surged in recent weeks. As a share of total gross market value in the bank’s Prime ...
ANN ARBOR, Mich. - On Tuesday, Esperion Therapeutics Inc. (NASDAQ:ESPR) reported fourth quarter adjusted earnings per share of $0.22, missing analyst estimates of $0.29, while revenue of $168.4 ...
Investing.com -- The Kremlin stated on Tuesday that the potential removal of U.S. sanctions on Russian oil has not been discussed in detail with Washington. The comments come amid reports that the ...
Investing.com -- South Africa’s economy expanded by 0.4% quarter-on-quarter in the final quarter of 2025, a modest increase from the revised 0.3% growth recorded in the third quarter, supported by ...
Investing.com -- MiNK Therapeutics (NASDAQ:INKT) shares surged 80% Tuesday following the announcement of a collaboration with C-Further to develop a PRAME-targeted iNKT cell therapy for pediatric ...